Report      Database

    Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast

    Date: 10 Nov, 2017              Type: Medical Devices              Pages: 187

    Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast
    • Electronic Access - Single User License
      $1,999.00
    • CD-ROM Mail Delivery
      $2,099.00
    • Hard-copy Mail Delivery
      $2,249.00
    • Electronic Access - Multi User License
      $2,799.00

    Get Free Customization in This Report

    Global CGM market will be an US$ 4 Billion opportunity by 2024. This report provides the market data on, continuous glucose monitoring (CGM) systems market of 11 countries globally. In the report CGM market has been divided into 2 components: glucose sensors and CGM transmitters. Transmitters & receivers along with sensors are known as standalone CGM systems, which are preinstalled by manufacturer. Sensors are disposable items, which is replaced after every 5-7 days. By geography, this market is studied with respect to major Industrialized Countries (United States, United Kingdom, Israel, Germany, France, Netherlands, Sweden, Switzerland, Australia, Japan and Canada).


    United States has the Highest CGM Market Globally 

    CGM (Continuous Glucose Monitor) is extremely relevant to almost all age groups to manage diabetes efficiently and effectively. United States controls the global CGM Market. In Europe Germany and France CGM market has grown to a noticeable strength. According to many experts CGM is the best device for proper diabetes management for those having severe diabetes complications occurred periodically.


    Request a free sample copy of the report: http://www.renub.com/contactus.php


    Countries Specific CGM Reimbursement details are covered in this Report

    CGM reimbursement is still in its infancy stages in many countries but policy has been expanding over a period of time and addition of technological device under diabetes management is implemented by many countries. At present CGM is reimbursed for pediatric, gestational diabetes and Type 1 diabetes patients in some countries and it is expected that it will be accessible to all diabetes patients in due course of time. As countries are continuously expanding their diabetes management policy and several positive assessments are being done in favor of CGM it is expected to drive the market in future.

    Renub Research latest study “Global CGM Market, Users, Reimbursement Policy, CGM Components (Glucose Sensor, Transmitter) Market, Diabetes (Type1 & 2) Population, & Forecast” provides a detailed and comprehensive insight of the Global CGM Market. This 187 page report with 163 Figures and 4 Tables studies the Continuous Glucose Monitoring (CGM) market from 3 view points:  

    •    CGM Market
    •    CGM Users
    •    CGM Reimbursements Policy


    Scope of the Report

    •    CGM Market & Forecast: We have defined CGM market of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024

    •    CGM Users & Forecast: We have defined CGM number of Users of 11 countries. Market data from 2010 to 2016 and Forecast from 2017 to 2024

    •    Reimbursement Policy: Report provides Reimbursement Policy on CGM for 11 countries individually along with global CGM (Continuous Glucose Monitoring) reimbursement model

    •    Diabetes Population: Report covers 11 Countries Type 1 and Type 2 Diabetes Population Numbers and Forecast

    •    Growth Factors for CGM: This topic studies the factors which is helping the CGM industry to grow

    •    Challenges for CGM: This industry shows the problems being faced by the CGM technology


    Countries Covered

    1.    United States
    2.    Canada 
    3.    Germany 
    4.    Australia 
    5.    France 
    6.    Netherlands
    7.    Switzerland
    8.    Sweden 
    9.    Israel 
    10.    United Kingdom
    11.    Japan

     

    Key Questions Answered in the Report?   
     
    •    What is the Global CGM Market & its growth forecast?  
        What are the Global CGM Users & its growth forecast?
        What is the CGM market & forecast in 11 countries globally? 
        What is the CGM users & forecast in 11 countries globally? 
        What is the CGM reimbursement policy in each of these 11 countries?

    1.    Executive Summary

    2.    Global – CGM User (2010 – 2024)

    3.    Global – CGM Market & Forecast (2010 – 2024)

    4.    By Components – CGM Market (2010 – 2024)
    4.1    Glucose Sensor Market & Forecast

    4.2    CGM Transmitter Market & Forecast

    5.    Market Share – By Countries

    6.    Global CGM (Continuous Glucose Monitoring) Reimbursement Model

    7.    Abbott Freestyle Libre vs CGM (Continuous Glucose Monitoring)

    8.    United States – Diabetes Population (2010 – 2024)
    8.1    United States Total Diabetes Population
    8.1.1    United States Type 1 Diabetes Population
    8.1.2    United States Type 2 Diabetes Population

    9.    United States – CGM Market & Forecast
    9.1    United States - CGM Market by Components
    9.1.1    Glucose Sensor Market & Forecast
    9.1.2    CGM Transmitter Market & Forecast

    10.    United States – CGM User (2010 – 2024)

    11.    CGM Reimbursement in United States

    12.    United Kingdom – Diabetes Population (2010 – 2024)
    12.1    United Kingdom – Total Diabetes Population
    12.1.1    United Kingdom Type 1 Diabetes Population
    12.1.2    United Kingdom Type 2 Diabetes Population

    13.    United Kingdom - CGM Market & Forecast
    13.1    United Kingdom - CGM Market by Components
    13.1.1    Glucose Sensor Market & Forecast
    13.1.2    CGM Transmitter Market & Forecast

    14.    United Kingdom – CGM User (2010 – 2024)

    15.    CGM Reimbursement in United Kingdom

    16.    Israel – Diabetes Population (2010 – 2024)
    16.1    Israel – Total Diabetes Population & Forecast
    16.1.1    Type 1 Diabetes Population
    16.1.2    Type 2 Diabetes Population

    17.    Israel - CGM Market & Forecast
    17.1    Israel - CGM Market by Components
    17.1.1    Glucose Sensor Market & Forecast
    17.1.2    CGM Transmitter Market & Forecast

    18.    Israel – CGM User (2010 – 2024)

    19.    CGM Reimbursement in Israel

    20.    Germany – Diabetes Population (2010 – 2024)
    20.1    Germany – Total Diabetes Population
    20.1.1    Type 1 Diabetes Population
    20.1.2    Type 2 Diabetes Population

    21.    Germany - CGM Market & Forecast
    21.1    Germany - CGM Market by Components
    21.1.1    Glucose Sensor Market & Forecast
    21.1.2    CGM Transmitter Market & Forecast

    22.    Germany – CGM User (2010 – 2024)

    23.    CGM Reimbursement in Germany

    24.    Netherlands – Diabetes Population (2010 – 2024)
    24.1    Netherlands – Total Diabetes Population
    24.1.1    Type 1 Diabetes Population
    24.1.2    Type 2 Diabetes Population

    25.    Netherlands - CGM Market & Forecast
    25.1    Netherlands - CGM Market by Components
    25.1.1    Glucose Sensor Market & Forecast
    25.1.2    CGM Transmitter Market & Forecast

    26.    Netherlands – CGM User (2010 – 2024)

    27.    CGM Reimbursement in Netherlands

    28.    Sweden – Diabetes Population (2010 – 2024)
    28.1    Sweden – Total Diabetes Population & Forecast
    28.1.1    Type 1 Diabetes Population
    28.1.2    Type 2 Diabetes Population

    29.    Sweden - CGM Market & Forecast
    29.1    Sweden – CGM Market by Components
    29.1.1    Glucose Sensor Market & Forecast
    29.1.2    CGM Transmitter Market & Forecast

    30.    Sweden – CGM User (2010 – 2024)

    31.    CGM Reimbursement in Sweden

    32.    France – Diabetes Population (2010 – 2024)
    32.1    France – Diabetes Population
    32.1.1    Type 1 Diabetes Population
    32.1.2    Type 2 Diabetes Population

    33.    France - CGM Market & Forecast
    33.1    France - CGM Market by Components
    33.1.1    Glucose Sensor Market & Forecast
    33.1.2    CGM Transmitter Market & Forecast

    34.    France – CGM User (2010 – 2024)

    35.    CGM Reimbursement in France

    36.    Switzerland – Diabetes Population (2010 – 2024)
    36.1    Switzerland – Total Diabetes Population
    36.1.1    Type 1 Diabetes Population
    36.1.2    Type 2 Diabetes Population

    37.    Switzerland - CGM Market & Forecast
    37.1    Switzerland - CGM Market by Components
    37.1.1    Glucose Sensor Market & Forecast
    37.1.2    CGM Transmitter Market & Forecast

    38.    Switzerland – CGM User (2010 – 2024)

    39.    CGM Reimbursement in Switzerland

    40.    Australia – Diabetes Population (2010 – 2024)
    40.1    Australia – Total Diabetes Population
    40.1.1    Type 1 Diabetes Population
    40.1.2    Type 2 Diabetes Population

    41.    Australia - CGM Market & Forecast
    41.1    Australia - CGM Market by Components
    41.1.1    Glucose Sensor Market & Forecast
    41.1.2    CGM Transmitter Market & Forecast

    42.    Australia – CGM User (2010 – 2024)

    43.    CGM Reimbursement in Australia

    44.    Japan – Diabetes Population (2010 – 2024)
    44.1    Japan – Total Diabetes Population
    44.1.1    Type 1 Diabetes Population
    44.1.2    Type 2 Diabetes Population

    45.    Japan - CGM Market & Forecast
    45.1    Japan - CGM Market by Components
    45.1.1    Japan – Glucose Sensor Market & Forecast
    45.1.2    Japan – CGM Transmitter Market & Forecast

    46.    Japan – CGM User (2010 – 2024)

    47.    CGM Reimbursement in Japan

    48.    Canada – Diabetes Population (2010 – 2024)
    48.1    Canada Diabetes Population
    48.1.1    Type 1 Diabetes Population
    48.1.2    Type 2 Diabetes Population

    49.    Canada - CGM Market & Forecast
    49.1    Canada - CGM Market by Components
    49.1.1    Glucose Sensor Market & Forecast
    49.1.2    CGM Transmitter Market & Forecast

    50.    Canada – CGM User (2010 – 2024)

    51.    CGM Reimbursement in Canada

    52.    Market Dynamics
    52.1    Growth Drivers
    52.1.1    Continuous Positive Cost Effective Analysis by Several Countries
    52.1.2    CGM Technology Convenient for both Patients & Physicians

    52.2    Challenges
    52.2.1    Controversy regarding Clinical Benefits

     

    List of Figures

    Figure 2‑1: Global – CGM User (Number), 2010 – 2016
    Figure 2‑2: Global – Forecast for CGM User (Number), 2017 – 2024

    Figure 3‑1: Global – CGM Market (Million US$), 2010 – 2016
    Figure 3‑2: Global – Forecast for CGM Market (Million US$), 2017 – 2024

    Figure 4‑1: Global – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 4‑2: Global – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 4‑3: Global – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 4‑4: Global – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 7‑1: Abbott Freestyle Libre – User in Europe & Global (Number), May 2017

    Figure 8‑1: United States – Diabetes Population (Thousand), 2010 - 2016
    Figure 8‑2: United States – Forecast for Diabetes Population (Thousand), 2017 - 2024
    Figure 8‑3: United States – Type 1 Diabetes Population (Thousand), 2010 - 2016
    Figure 8‑4: United States – Forecast for Type 1 Diabetes Population (Thousand), 2017 - 2024
    Figure 8‑5: United States: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 8‑6: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 9‑1: United States – CGM Market (Million US$), 2010 – 2016
    Figure 9‑2: United States – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 9‑3: United States – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 9‑4: United States – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 9‑5: United States – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 9‑6: United States – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 10‑1: United States – CGM User (Number), 2010 – 2016
    Figure 10‑2: United States – Forecast for CGM User (Number), 2017 – 2024

    Figure 12‑1: United Kingdom: Diabetes Population (Thousand), 2010 – 2016
    Figure 12‑2: United Kingdom: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 12‑3: United Kingdom: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 12‑4: United Kingdom: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 12‑5: United Kingdom: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 12‑6: United Kingdom: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 13‑1: United Kingdom – CGM Market (Million US$), 2010 – 2016
    Figure 13‑2: United Kingdom – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 13‑3: United Kingdom – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 13‑4: United Kingdom – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 13‑5: United Kingdom – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 13‑6: United Kingdom – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 14‑1: United Kingdom – CGM User (Number), 2010 – 2014
    Figure 14‑2: United Kingdom – Forecast for CGM User (Number), 2017 – 2024

    Figure 16‑1: Israel: Diabetes Population (Thousand), 2010 – 2016
    Figure 16‑2: Israel: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 16‑3: Israel: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 16‑4: Israel: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 16‑5: Israel: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 16‑6: Israel: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 17‑1: Israel – CGM Market (Million US$), 2010 – 2016
    Figure 17‑2: Israel – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 17‑3: Israel – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 17‑4: Israel – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 17‑5: Israel – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 17‑6: Israel – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 18‑1: Israel – CGM User (Number), 2010 – 2016
    Figure 18‑2: Israel – Forecast for CGM User (Number), 2017 – 2024

    Figure 20‑1: Germany: Diabetes Population (Thousand), 2010 – 2016
    Figure 20‑2: Germany: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 20‑3: Germany: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 20‑4: Germany: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 20‑5: Germany: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 20‑6: Germany: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 21‑1: Germany – CGM Market (Million US$), 2010 – 2016
    Figure 21‑2: Germany – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 21‑3: Germany – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 21‑4: Germany – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 21‑5: Germany – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 21‑6: Germany – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 22‑1: Germany – CGM User (Number), 2010 – 2016
    Figure 22‑2: Germany – Forecast for CGM User (Number), 2017 – 2024

    Figure 24‑1: Netherlands: Diabetes Population (Thousand), 2010 – 2016
    Figure 24‑2: Netherlands: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 24‑3: Netherlands: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 24‑4: Netherlands: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 24‑5: Netherlands: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 24‑6: Netherlands: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 25‑1: Netherlands – CGM Market (Million US$), 2010 – 2016
    Figure 25‑2: Netherlands – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 25‑3: Netherlands – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 25‑4: Netherlands – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 25‑5: Netherlands – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 25‑6: Netherlands – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 26‑1: Netherlands – CGM User (Number), 2010 – 2016
    Figure 26‑2: Netherlands – Forecast for CGM User (Number), 2017 – 2024

    Figure 28‑1: Sweden: Diabetes Population (Thousand), 2010 – 2016
    Figure 28‑2: Sweden: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 28‑3: Sweden: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 28‑4: Sweden: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 28‑5: Sweden: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 28‑6: Sweden: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 29‑1: Sweden – CGM Market (Million US$), 2010 – 2016
    Figure 29‑2: Sweden – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 29‑3: Sweden – Glucose Sensor Market (Million US$), 2010 -2016
    Figure 29‑4: Sweden – Forecast for Glucose Sensor Market (Million US$), 2017 -2024
    Figure 29‑5: Sweden – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 29‑6: Sweden – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 30‑1: Sweden – CGM User (Number), 2010 – 2016
    Figure 30‑2: Sweden – Forecast for CGM User (Number), 2017 – 2024

    Figure 32‑1: France – Diabetes Population (Thousand), 2010 – 2016
    Figure 32‑2: France – Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 32‑3: France – Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 32‑4: France – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 32‑5: France – Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 32‑6: France – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 33‑1: France – CGM Market (Million US$), 2010 – 2016
    Figure 33‑2: France – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 33‑3: France – Glucose Sensor Market (Million), 2010 – 2016
    Figure 33‑4: France – Forecast for Glucose Sensor Market (Million), 2017 – 2024
    Figure 33‑5: France – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 33‑6: France – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 34‑1: France – CGM User (Number), 2010 -2016
    Figure 34‑2: France – Forecast for CGM User (Number), 2017 -2024

    Figure 36‑1: Switzerland: Diabetes Population (Thousand), 2010 – 2016
    Figure 36‑2: Switzerland: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 36‑3: Switzerland: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 36‑4: Switzerland: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 36‑5: Switzerland: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 36‑6: Switzerland: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 37‑1: Switzerland – CGM Market (Million US$), 2010 – 2016
    Figure 37‑2: Switzerland – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 37‑3: Switzerland – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 37‑4: Switzerland – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 37‑5: Switzerland – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 37‑6: Switzerland – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 38‑1: Switzerland – CGM User (Number), 2010 – 2016
    Figure 38‑2: Switzerland – Forecast for CGM User (Number), 2017 – 2024

    Figure 40‑1: Australia: Diabetes Population (Thousand), 2010 – 2016
    Figure 40‑2: Australia: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 40‑3: Australia: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 40‑4: Australia: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 40‑5: Australia: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 40‑6: Australia: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 41‑1: Australia – CGM Market (Million US$), 2010 – 2016
    Figure 41‑2: Australia – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 41‑3: Australia – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 41‑4: Australia – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 41‑5: Australia – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 41‑6: Australia – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 42‑1: Australia – CGM User (Number), 2010 – 2016
    Figure 42‑2: Australia – Forecast for CGM User (Number), 2017 – 2024

    Figure 44‑1: Japan: Diabetes Population (Thousand), 2010 – 2016
    Figure 44‑2: Japan: Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 44‑3: Japan: Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 44‑4: Japan: Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 44‑5: Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 44‑6: Japan: Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 45‑1: Japan – CGM Market (Million US$), 2010 – 2016
    Figure 45‑2: Japan – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 45‑3: Japan – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 45‑4: Japan – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 45‑5: Japan – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 45‑6: Japan – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 46‑1: Japan – CGM User (Number), 2010 – 2016
    Figure 46‑2: Japan – Forecast for CGM User (Number), 2017 – 2024

    Figure 48‑1: Canada – Diabetes Population (Thousand), 2010 – 2016
    Figure 48‑2: Canada – Forecast for Diabetes Population (Thousand), 2017 – 2024
    Figure 48‑3: Canada – Type 1 Diabetes Population (Thousand), 2010 – 2016
    Figure 48‑4: Canada – Forecast for Type 1 Diabetes Population (Thousand), 2017 – 2024
    Figure 48‑5: Canada – Type 2 Diabetes Population (Thousand), 2010 – 2016
    Figure 48‑6: Canada – Forecast for Type 2 Diabetes Population (Thousand), 2017 – 2024

    Figure 49‑1: Canada – CGM Market (Million US$), 2010 – 2016
    Figure 49‑2: Canada – Forecast for CGM Market (Million US$), 2017 – 2024
    Figure 49‑3: Canada – Glucose Sensor Market (Million US$), 2010 – 2016
    Figure 49‑4: Canada – Forecast for Glucose Sensor Market (Million US$), 2017 – 2024
    Figure 49‑5: Canada – CGM Transmitter Market (Million US$), 2010 – 2016
    Figure 49‑6: Canada – Forecast for CGM Transmitter Market (Million US$), 2017 – 2024

    Figure 50‑1: Canada – CGM User (Number), 2010 – 2016
    Figure 50‑2: Canada – Forecast for CGM User (Number), 2017 – 2024


     

    List of Tables

    Table 3‑1: Global – CGM Market Share (Percent), 2010 – 2016
    Table 3‑2: Global – Forecast for CGM Market Share (Percent), 2017 – 2024

    Table 6‑1: Current Status of Global Real-Time Continuous Glucose Monitoring Coverage and Reimbursement, 2017

    Table 7‑1: Abbott Freestyle Libre vs. CGM
     


    Related Products